Neuropace
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neuropace and other ETFs, options, and stocks.About NPCE
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads.
CEOJoel D. Becker
CEOJoel D. Becker
Employees184
Employees184
HeadquartersMountain View, California
HeadquartersMountain View, California
Founded1997
Founded1997
Employees184
Employees184
NPCE Key Statistics
Market cap533.26M
Market cap533.26M
Price-Earnings ratio-21.49
Price-Earnings ratio-21.49
Dividend yield—
Dividend yield—
Average volume233.27K
Average volume233.27K
High today$16.39
High today$16.39
Low today$15.94
Low today$15.94
Open price$16.39
Open price$16.39
Volume58.41K
Volume58.41K
52 Week high$18.98
52 Week high$18.98
52 Week low$7.56
52 Week low$7.56
Stock Snapshot
The current Neuropace(NPCE) stock price is $16.01, with a market capitalization of 533.26M. The stock trades at a price-to-earnings (P/E) ratio of -21.49.
During the trading session on 2025-12-15, Neuropace(NPCE) shares reached a daily high of $16.39 and a low of $15.94. At a current price of $16.01, the stock is +0.4% higher than the low and still -2.3% under the high.
Trading activity shows a volume of 58.41K, compared to an average daily volume of 233.27K.
The stock's 52-week range extends from a low of $7.56 to a high of $18.98.
The stock's 52-week range extends from a low of $7.56 to a high of $18.98.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own NPCE. This list is generated using Robinhood data, and it’s not a recommendation.